Emory Innovation Hub, Konica Minolta team on imaging, personalized med

Emory Healthcare will work on several imaging and personalized medicine initiatives through a new partnership involving its Innovation Hub.

The medical organization will team with Konica Minolta Healthcare Americas in a strategic partnership that primarily will focus on solutions that enhance diagnostic capabilities for clinicians. The partners say they will work together to innovate clinical pathways through the adoption of new technologies, as well as develop new solutions to advance personalized patient care.

Emory’s Innovation Hub was founded in 2018 as an innovation and commercialization program. Existing partners include Cerner, Novo Nordisk, Sharecare and Stryker. Part of Emory Healthcare integrated delivery system, the center is based in Atlanta.

Konica Minolta’s healthcare technology involves integrating medical imaging, informatics and genetics. Those capabilities are expected to be integrated with the academic research capabilities of Emory’s Woodruff Health Sciences Center, which is working on advancing consumer-driven healthcare solutions and the development of evidence-based data-driven healthcare applications.

Emory-CROP.jpg

Initially, Konica Minolta and the Emory’s Innovation Hub will focus on solutions that enhance diagnostic capabilities for clinicians and their patients in orthopedics and sports medicine, breast imaging and personalized medicine. Emory Healthcare will be the first clinical site to implement Konica Minolta‘s Dynamic Digital Radiography for orthopedics, making use of its enhanced X-ray technology that enables clinicians to observe the dynamic motion of anatomical structures over time, enhancing diagnostic capabilities.

The technology vendor’s Exa Mammo, a PACS designed specifically for breast imaging studies, will be implemented in the oncology department to provide rapid viewing of breast images, improving clinical workflow for the breast oncologists. The organizations will also explore new solutions and approaches in precision medicine and the further integration of genetics in care delivery with Ambry Genetics, a Konica Minolta company.

“With Konica Minolta and the resource of the Emory Healthcare Innovation Hub ecosystem, we will broaden the connection between digital imaging, genetics and drug discovery in the diagnosis and management of injuries and diseases,” says Scott D. Boden, MD, vice president of business innovation for Emory Healthcare, and the chief medical and quality officer for Emory University Orthopaedics & Spine Hospital.

For reprint and licensing requests for this article, click here.